The Ordinary Azelaic Acid Suspension 10%

The Ordinary is a disruptive skincare brand known for its clinical technologies and honest pricing. It was originally launched in 2016 by DECIEM (The Abnormal Beauty Company) in Toronto, Canada.

The products are primarily manufactured at DECIEM's own facilities in Canada, maintaining high quality standards and direct control over formulations. The brand's philosophy centers on transparency in ingredients, often highlighting specific acids or vitamins.

Following a series of investments and a majority stake acquisition, the Estée Lauder Companies completed the full acquisition of DECIEM in 2024. This makes The Ordinary part of one of the world's largest prestige beauty conglomerates based in the United States, though many of its operations and manufacturing remain rooted in its Canadian origin.